Summary
Matrix metalloproteinase 2 (MMP-2)/gelatinase A plays an important role in tumour invasion and metastasis. Since MMP-2 is secreted as an inactive form (proMMP-2) from tumour and neighbouring stroma cells, the activation process is necessary to express the enzymic activity for degradation of extracellular matrix components. We herein reported that the activation of proMMP-2 was induced in human squamous carcinoma cells co-cultured with normal human dermal fibroblasts. When A431 cells were co-cultured with human fibroblasts at various cell ratios, 72-kDa proMMP-2 was converted to a 62-kDa active form through the appearance of a 64-kDa intermediate. The activation of proMMP-2 by co-culture was also observed in other carcinoma cell lines, HSC-4 and SAS, but not in normal human keratinocytes. We characterized by in vitro invasion assay that A431 cells in co-culture preferentially invaded through Matrigel and the increased invasive activity was inhibited by exogenously adding tissue inhibitor of metalloproteinases 2. The augmented proMMP-2 activation by co-culture was achieved by the increase in membrane type 1-MMP (MT1-MMP) production along with that of its mRNA level. The predominant appearance of MT1-MMP was immunologically observed in A431 cells, but not human fibroblasts of the co-culture. Furthermore, epidermal growth factor (EGF) enhanced the co-culture-mediated proMMP-2 activation by increasing the production and gene expression of MT1-MMP, and thereby tumour invasive activity was further augmented. These results suggest that the cell–cell contact between carcinoma cells and normal fibroblasts enhances the production of MT1-MMP followed by sequential activation of proMMP-2 on the tumour cell surface, which may be closely implicated in tumour invasion in vivo.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Azzam, H., Arand, G., Lippman, M. E. & Thompson, E. W. (1993). Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 1758–1764.
Baramova, E. N., Bajou, K., Remacle, A., L’Hoir, C., Krell, H. W., Weidle, U. H., Noel, A. & Foidart, J. M. (1997). Involvement of PA/plasmin system in the processing of proMMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 405: 157–162.
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. & Engler, J. A. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197–250.
Bronner-Fraser, M. (1985). Alterations in neural crest migration by a monoclonal antibody that affects cell adhesion. J Cell Biol 101: 610–617.
Ito, A. & Nagase, H. (1988). Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys 267: 211–2216.
Ito, A., Itoh, Y., Sato, T., Mori, Y., Suzuki, K. & Nagase, H. (1991). Identification of rabbit uterine cervical procollagenase activator as rabbit matrix metalloproteinase 3 (stromelysin). Comp Biochem Physiol 99B: 381–385.
Ito, A., Nakajima, S., Sasaguri, Y., Nagase, H. & Mori, Y. (1995). Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 71: 1039–1045.
Ito, A., Yamada, M., Sato, T., Sanekata, K., Sato, H., Seiki, M., Nagase, H. & Mori, Y. (1998). Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts. Eur J Biochem 251: 353–358.
Itoh, Y., Binner, S. & Nagase, H. (1995). Steps involved in activation of the complex of promatrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J 308: 645–651.
Kinoshita, T., Sato, H., Takino, T., Itoh, M., Akizawa, T. & Seiki, M. (1996). Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 56: 2535–2538.
Kinoshita, T., Sato, H., Okada, A., Ohuchi, E., Imai, K., Okada, Y. & Seiki, M. (1998). TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 273: 16098–16103.
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680–685.
Lohi, J. & Keski-Oja, J. (1995). Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem 270: 17602–17609.
Lohi, J., Lehti, K., Westermarck, J., Kähäri, V-M & Keski-Oja, J. (1996). Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239: 239–247.
Lowry, O. H., Rosebrough, N. J., Lewis Farr, A. & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S. & Mignatti, P. (1997). Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 16: 2319–2332.
Ogata, Y., Enghild, J. J. & Nagase, H. (1992). Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267: 3581–3584.
Okada, Y., Morodomi, T., Enghild, J. J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G. & Nagase, H. (1990). Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194: 721–730.
Ozawa, S., Ueda, M., Ando, N., Abe, O. & Shimizu, N. (1987). High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas. Int J Cancer 39: 333–337.
Pei, D. & Weiss, S. J. (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271: 9135–9140.
Polette, M., Gilles, C., Marchard, V., Seiki, M., Tournier, J-M & Birembaut, P. (1997). Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells. Clin Exp Metastasis 15: 157–163.
Puente, X. S., Pendás, A. M., Llano, E., Velasco, G. & López-OtÃn, C. (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56: 944–949.
Pyke, C., Ralfkiær, E., Huhtala, P., Hurskainen, T., Danø, K. & Tryggvason, K. (1992). Localization of messenger RNA for Mr 72 000 and 92 000 type IV collagenase in human skin cancers by in situ hybridization. Cancer Res 52: 1336–1341.
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. & Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61–65.
Sato, T., Kirimura, Y. & Mori, Y. (1997). The co-culture of dermal fibroblasts with human epidermal keratinocytes induces increased prostaglandin E2 production and cyclooxygenase 2 activity in fibroblasts. J Invest Dermatol 109: 334–339.
Seltzer, J. L., Lee, A-Y, Akers, K. T., Sudbeck, B., Southon, E. A., Wayner, E. A. & Eisen, A. Z. (1994). Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res 213: 365–374.
Shima, I., Sasaguri, Y., Kusukawa, J., Nakano, R., Yamana, H., Fujita, H., Kakegawa, T. & Morimatsu, M. (1993). Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br J Cancer 67: 721–727.
Singletary, S. E., Baker, F. L., Spitzer, G., Tucker, S. L., Tomasovic, B., Brock, W. A., Ajani, J. A. & Kelly, A. M. (1987). Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res 47: 403–406.
Stearns, M. E. & Wang, M. (1993). Type IV collagenase (Mr 72 000) expression in human prostate: benign and malignant tissue. Cancer Res 53: 878–883.
Stetler-Stevenson, W. G., Aznavoorian, S. & Liotta, L. A. (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541–573.
Strongin, A. Y., Marmer, B. L., Grant, G. A. & Goldberg, G. I. (1993). Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268: 14033–14039.
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. & Goldberg, G. I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloproteinase. J Biol Chem 270: 5331–5338.
Takahashi, S., Ito, A., Nagino, M., Mori, Y., Xie, B. & Nagase, H. (1991). Cyclic adenosine 3′, 5′-monophosphate suppresses interleukin 1-induced synthesis of matrix metalloproteinases but not of tissue inhibitor of metalloproteinases in human uterine cervical fibroblasts. J Biol Chem 266: 19894–19899.
Takino, T., Sato, H., Shinagawa, A. & Seiki, M. (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library: MT-MMPs from a unique membrane-type subclass in the MMP family. J Biol Chem 270: 23013–23020.
Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M. & Okada, Y. (1997). Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57: 2055–2060.
Ward, R. V., Atkinson, S. J., Slocombe, P. M., Docherty, A. J. P., Reynolds, J. J. & Murphy, G. (1991). Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim Biophys Acta 1079: 242–246.
Westerlund, A., Hujanen, E., Puistola, U. & Turpeenniemi-Hujanen, T. (1997). Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2). Gynecol Oncol 67: 76–82.
Will, H. & Hinzmann, B. (1995). cDNA sequence and mRNA distribution of a novel human matrix metalloproteinase with a potential transmembrane domain. Eur J Biochem 231: 602–608.
Will, H., Atkinson, S. J., Butler, G. S., Smith, B. & Murphy, G. (1996). The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation: regulation by TIMP-2 and TIMP-3. J Biol Chem 271: 17119–17123.
Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G. N., Seiki, M., Sato, H., Gokaslan, Z. L., Liotta, L. A., Nicolson, G. L. & Rao, J. S. (1996). Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vitro and in vivo. Cancer Res 56: 384–392.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sato, T., Iwai, M., Sakai, T. et al. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Br J Cancer 80, 1137–1143 (1999). https://doi.org/10.1038/sj.bjc.6690477
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690477
Keywords
This article is cited by
-
Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation
Clinical & Experimental Metastasis (2009)
-
Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium
Reproductive Biology and Endocrinology (2008)
-
Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas
Modern Pathology (2004)
-
Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling
Oncogene (2003)